Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Lehman

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Science Translational Medicine|January 28, 2021
Toward robust mammography-based models for breast cancer riskAdam Yala, Peter G Mikhael, Fredrik Strand, et al.
Nature Medicine|January 14, 2022
Optimizing risk-based breast cancer screening policies with reinforcement learningAdam Yala, Peter G Mikhael, Constance Lehman, et al.
JNCI Cancer Spectrum|January 11, 2019
Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)Rinaa S Punglia, Kaitlyn Bifolck, Mehra Golshan, et al.
Breast Cancer Research and Treatment|July 29, 2011
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)Cheryl Lin, Meredith Becker Buxton, Dan Moore, et al.
Cancers|January 11, 2022
Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular SubtypesAnne Marie McCarthy, Yi Liu, Sarah Ehsan, et al.
British Journal of Cancer|February 17, 2017
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotypeOnofrio Antonio Catalano, Gary Lloyd Horn, Alberto Signore, et al.
Cancer Medicine|August 31, 2021
Relationship of established risk factors with breast cancer subtypesAnne Marie McCarthy, Tara Friebel-Klingner, Sarah Ehsan, et al.
JAMA Internal Medicine|February 14, 2018
Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast CancerDiana S M Buist, Linn Abraham, Christoph I Lee, et al.
NPJ Precision Oncology|September 22, 2021
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analysesSiang-Boon Koh, Brian N Dontchos, Veerle Bossuyt, et al.
Breast Cancer Research and Treatment|November 10, 2016
Using machine learning to parse breast pathology reportsAdam Yala, Regina Barzilay, Laura Salama, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Science Translational Medicine|January 28, 2021
Toward robust mammography-based models for breast cancer riskAdam Yala, Peter G Mikhael, Fredrik Strand, et al.
Nature Medicine|January 14, 2022
Optimizing risk-based breast cancer screening policies with reinforcement learningAdam Yala, Peter G Mikhael, Constance Lehman, et al.
JNCI Cancer Spectrum|January 11, 2019
Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)Rinaa S Punglia, Kaitlyn Bifolck, Mehra Golshan, et al.
Breast Cancer Research and Treatment|July 29, 2011
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)Cheryl Lin, Meredith Becker Buxton, Dan Moore, et al.
Cancers|January 11, 2022
Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular SubtypesAnne Marie McCarthy, Yi Liu, Sarah Ehsan, et al.
British Journal of Cancer|February 17, 2017
PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotypeOnofrio Antonio Catalano, Gary Lloyd Horn, Alberto Signore, et al.
Cancer Medicine|August 31, 2021
Relationship of established risk factors with breast cancer subtypesAnne Marie McCarthy, Tara Friebel-Klingner, Sarah Ehsan, et al.
JAMA Internal Medicine|February 14, 2018
Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast CancerDiana S M Buist, Linn Abraham, Christoph I Lee, et al.
NPJ Precision Oncology|September 22, 2021
Systematic tissue collection during clinical breast biopsy is feasible, safe and enables high-content translational analysesSiang-Boon Koh, Brian N Dontchos, Veerle Bossuyt, et al.
Breast Cancer Research and Treatment|November 10, 2016
Using machine learning to parse breast pathology reportsAdam Yala, Regina Barzilay, Laura Salama, et al.
Pageof 4